Co-Lisinopril-Mepha 10 mg/12.5 mg
Co-Lisinopril-Mepha 10 mg/12.5 mg is a medicine authorised by Swissmedic under authorisation number 56856. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 20 August 2004 and the authorisation is valid without a time limit. ATC code C09BA03 places the medicine in the group Agents acting on the renin-angiotensin system.
| Authorisation number | 56856 |
|---|---|
| Name | Co-Lisinopril-Mepha 10 mg/12.5 mg |
| Full name | Co-Lisinopril-Mepha 10 mg/12.5 mg, Tabletten |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C09BA03 |
| First authorisation | 20 August 2004 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Co-Lisinopril-Mepha 10 mg/12.5 mg, Tabletten | B | 20 August 2004 |
| 2 | Co-Lisinopril-Mepha 20 mg/12.5 mg, Tabletten | B | 20 August 2004 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Tablette(n) | C09BA03 | 02.07.2. | B |
| 2 | 100 | Tablette(n) | C09BA03 | 02.07.2. | B |
| 3 | 30 | Tablette(n) | C09BA03 | 02.07.2. | B |
| 4 | 100 | Tablette(n) | C09BA03 | 02.07.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Co-Lisinopril-Mepha 10 mg/12.5 mg authorised in Switzerland?
Yes. Co-Lisinopril-Mepha 10 mg/12.5 mg is authorised by Swissmedic under authorisation number 56856, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Co-Lisinopril-Mepha 10 mg/12.5 mg have?
Co-Lisinopril-Mepha 10 mg/12.5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Co-Lisinopril-Mepha 10 mg/12.5 mg?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.